Although the US women's health imaging system market is saturated and unit sales are largely limited to replacement contracts, the growing popularity of emerging breast imaging technologies, such as DBT, will spur modest growth in this market.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for women's health imaging systems in the US across a 10-year period.
The breast imaging system market will grow through 2024 due to the rising adoption of secondary breast diagnostic modalities.
How will the uncertainty over breast screening guidelines and the issue of screening dense breast tissue affect demand in this market?
How will the uptake of secondary screening technologies, such as dedicated breast MRI and BSGI, affect this market?
The rapidly expanding DBT segment will heavily impact the overall market for women's health imaging systems.
To what extent will the DBT segment support the breast imaging systems and overall women's health imaging systems markets?
Which vendors are active in this segment and how do they compete?
What implications follow the growing interest of DBT, both as a supplementary diagnostic tool and as a potential replacement for mammography screening?
The OB/GYN ultrasound system market will expand through 2024.
What capabilities should players in the OB/GYN market segment offer in their systems to maintain market share going forward?
- Women's Health Imaging Systems - Market Insights - United States
Author(s): Benjamin Li, BBA
Benjamin Li is a team lead within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Decision Resources Group, with extensive knowledge in healthcare IT, women's health imaging, urology, large-joint reconstruction, spinal implants, and dental implants. Benjamin holds a Bachelor's degree in Business Administration from the Schulich School of Business, with a certificate in Managing International Trade and Investment.